Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016 (2016), Article ID 8797206, 15 pages
http://dx.doi.org/10.1155/2016/8797206
Review Article

HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory Diseases

1Biomedical Sciences Program, Midwestern University, 19555 N 59th Avenue, Glendale, AZ 85308, USA
2Department of Microbiology & Immunology, Arizona College of Osteopathic Medicine, Midwestern University, 19555 N 59th Avenue, Glendale, AZ 85308, USA

Received 20 February 2016; Revised 8 June 2016; Accepted 29 June 2016

Academic Editor: Masahiko Hatano

Copyright © 2016 Elizabeth E. Hull et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Elizabeth E. Hull, McKale R. Montgomery, and Kathryn J. Leyva, “HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory Diseases,” BioMed Research International, vol. 2016, Article ID 8797206, 15 pages, 2016. doi:10.1155/2016/8797206